CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Campaign for Better Health Care

Campaign for Better Health Care is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Care/of

Get vitamins and supplements for your health goals and diet, made from the best ingredients, shipped to you each month.

Instrumed International

Instrumed International is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ashwood Retirement and Assisted

Ashwood Retirement and Assisted is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aya Healthcare

Aya Healthcare creates exceptional experiences – for their clinicians, their corporate employees and the healthcare facilities they serve. For healthcare facilities, Aya delivers a robust suite of software and services to manage the procurement of contingent labor. Aya’s platform provides access to one of the largest sources of contract clinicians in the country which improves efficiency, increases quality and reduces costs for healthcare systems. For travel nurses, Aya delivers the best experience in the industry and allows access to the widest base of travel assignments in the United States.